1-12 of 12
b-cell lymphomas
Close
Sort by
Journal Articles

Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma

Clinical Trials & Observations
C. Perry, E. Luttwak, R. Balaban, G. Shefer, M. M. Morales, A. Aharon, Y. Tabib, Y. C. Cohen, N. Benyamini, O. Beyar-Katz, M. Neaman, R. Vitkon, N. Keren-Khadmy, M. Levin, Y. Herishanu, I. Avivi
Journal: Blood Advances
Blood Adv (2021) 5 (16): 3053–3061.
https://doi.org/10.1182/bloodadvances.2021005094
Published: 2021
Journal Articles

Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas

Clinical Trials & Observations
Nora Liebers, Johannes Duell, Donnacha Fitzgerald, Andrea Kerkhoff, Daniel Noerenberg, Eva Kaebisch, Fabian Acker, Stephan Fuhrmann, Corinna Leng, Manfred Welslau, Jens Chemnitz, Jan-Moritz Middeke, Thomas Weber, Udo Holtick, Ralf Trappe, Roald Pfannes, Ruediger Liersch, Christian Spoer, Stefan Fuxius, Niklas Gebauer, Léandra Caillé, Thomas Geer, Christian Koenecke, Ulrich Keller, Rainer Claus, Dimitrios Mougiakakos, Stephanie Mayer, Andreas Huettmann, Christiane Pott, Arne Trummer, Gerald Wulf, Uta Brunnberg, Lars Bullinger, Georg Hess, Carsten Mueller-Tidow, Bertram Glass, Georg Lenz, Peter Dreger, Sascha Dietrich
Journal: Blood Advances
Blood Adv (2021) 5 (13): 2707–2716.
https://doi.org/10.1182/bloodadvances.2020004155
Published: 2021
Includes: Supplemental data
Journal Articles

Microbial dysbiosis is associated with aggressive histology and adverse clinical outcome in B-cell non-Hodgkin lymphoma

Clinical Trials & Observations
Catherine S. Diefenbach, Brandilyn A. Peters, Huilin Li, Bruce Raphael, Tibor Moskovits, Kenneth Hymes, Jonas Schluter, J. Chen, N. Nora Bennani, Thomas E. Witzig, Jiyoung Ahn
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1194–1198.
https://doi.org/10.1182/bloodadvances.2020003129
Published: 2021
Includes: Supplemental data
Journal Articles

Expression of the prosurvival kinase HCK requires PAX5 and mutated MYD88 signaling in MYD88-driven B-cell lymphomas

Xia Liu, Jiaji G. Chen, Manit Munshi, Zachary R. Hunter, Lian Xu, Amanda Kofides, Nickolas Tsakmaklis, Maria G. Demos, Maria Luisa Guerrera, Gloria G. Chan, Cristina Jimenez, Christopher J. Patterson, Kirsten Meid, Andrew Keezer, Jorge J. Castillo, Steven P. Treon, Guang Yang
Journal: Blood Advances
Blood Adv (2020) 4 (1): 141–153.
https://doi.org/10.1182/bloodadvances.2019000947
Published: 2020
Journal Articles

E μ and 3′RR transcriptional enhancers of the IgH locus cooperate to promote c-myc–induced mature B-cell lymphomas

Nour Ghazzaui, Hussein Issaoui, Mélissa Ferrad, Claire Carrion, Jeanne Cook-Moreau, Yves Denizot, François Boyer
Journal: Blood Advances
Blood Adv (2020) 4 (1): 28–39.
https://doi.org/10.1182/bloodadvances.2019000845
Published: 2020
Includes: Supplemental data
Journal Articles

Long-term outcome of patients with relapsed/refractory B-cell non-Hodgkin lymphoma treated with blinatumomab

Clinical Trials & Observations
Vera Dufner, Cyrus M. Sayehli, Manik Chatterjee, Horst D. Hummel, Götz Gelbrich, Ralf C. Bargou, Maria-Elisabeth Goebeler
Journal: Blood Advances
Blood Adv (2019) 3 (16): 2491–2498.
https://doi.org/10.1182/bloodadvances.2019000025
Published: 2019
Includes: Supplemental data
Journal Articles

The role of aurora A and polo-like kinases in high-risk lymphomas

Clinical Trials & Observations
Carlos Murga-Zamalloa, Kedar V. Inamdar, Ryan A. Wilcox
Journal: Blood Advances
Blood Adv (2019) 3 (11): 1778–1787.
https://doi.org/10.1182/bloodadvances.2019000232
Published: 2019
Journal Articles

Venous thromboembolism in patients with B-cell non-Hodgkin lymphoma treated with lenalidomide: a systematic review and meta-analysis

Clinical Trials & Observations
Samuel Yamshon, Paul J. Christos, Michelle Demetres, Hoda Hammad, John P. Leonard, Jia Ruan
Journal: Blood Advances
Blood Adv (2018) 2 (12): 1429–1438.
https://doi.org/10.1182/bloodadvances.2018016683
Published: 2018
Includes: Supplemental data
Journal Articles

Checkpoint blockade in Hodgkin and non-Hodgkin lymphoma

Reid W. Merryman, Philippe Armand, Kyle T. Wright, Scott J. Rodig
Journal: Blood Advances
Blood Adv (2017) 1 (26): 2643–2654.
https://doi.org/10.1182/bloodadvances.2017012534
Published: 2017
Journal Articles

Patient-derived xenografts of low-grade B-cell lymphomas demonstrate roles of the tumor microenvironment

W. Richard Burack, Janice M. Spence, John P. Spence, Stephen A. Spence, Philip J. Rock, Gautam N. Shenoy, Leonard D. Shultz, Richard B. Bankert, Steven H. Bernstein
Journal: Blood Advances
Blood Adv (2017) 1 (16): 1263–1273.
https://doi.org/10.1182/bloodadvances.2017005892
Published: 2017
Includes: Supplemental data
Journal Articles

Genetic analysis of B-cell lymphomas associated with hemophagocytic lymphohistiocytosis

Kruti Patel, Sophia S. Lee, Poojitha Valasareddy, Namratha R. Vontela, Philippe Prouet, Mike G. Martin
Journal: Blood Advances
Blood Adv (2016) 1 (3): 205–207.
https://doi.org/10.1182/bloodadvances.2016002006
Published: 2016
Journal Articles

Targetable subsets of non-Hodgkin lymphoma in Malawi define therapeutic opportunities

Global Advances
Elizabeth A. Morgan, M. Patrick Sweeney, Tamiwe Tomoka, Nadja Kopp, Daniel Gusenleitner, Robert A. Redd, Christopher D. Carey, Leo Masamba, Steve Kamiza, Geraldine S. Pinkus, Donna S. Neuberg, Scott J. Rodig, Danny A. Milner, Jr, David M. Weinstock
Journal: Blood Advances
Blood Adv (2016) 1 (1): 84–92.
https://doi.org/10.1182/bloodadvances.2016000026
Published: 2016
Includes: Supplemental data